Adaptix secures STFC Bridging for Innovators grant…

Link to Full Article Adaptix have just won an STFC Bridging for Innovators (B4i) grant worth over £40,000 for work with the prestigious Ultra High Vacuum Group at STFC Daresbury – to develop cleaning processes for the manufacture of Adaptix’s patented Flat Panel X-ray Source. Bridging for Innovators (B4I) is an Industrial Strategy Challenge Fund (ISCF) programme run […]

Armata Pharmaceuticals Announces Second Quarter Results and Provides Corporate and Clinical Update

Link to Full Article MARINA DEL REY, Calif., Aug. 14, 2019 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced second quarter results and provided a corporate and clinical update. Key Second Quarter and Subsequent Period Highlights: Successfully completed […]

AVITA Medical Reports Fourth Quarter Fiscal 2019 Financial Results and Company Update

Link to Full Article • Total revenue of A$17.0 million for fiscal year 2019 (FY19), an increase of 50% year-over-year • U.S. product sales of A$6.2 million for FY19 • U.S. product sales of A$2.9 million for fourth quarter, an increase of 32% compared to FY third quarter sales Valencia, Calif., USA, and Melbourne, Australia, […]

SYNTHETIC WOUND HEALING MEMBRANE

Link to Full Article ‘Synthetic Amniotic Membrane’ development project supported InnovateUK and the UKI2S Accelerator Programme for Technology Development Projects. For many of us, there is hardly any more life-changing disability imaginable than loss of sight. Whether through trauma or disease, the inability to rely on visual cues impacts on all matters of daily […]

ADC BIO’S NEW STATE OF THE ART CLEAN ROOM FACILITY IS NOW READY TO SERVE GLOBAL CUSTOMER DEMANDS!

Click Link for full Article WHP COMPLETES CLEANROOM PROJECT FOR ADC BIO IN THE UK Production of new anti-cancer drugs at ADC Bio’s North Wales manufacturing plant has been boosted following completion of a new cleanroom facility. The project has been designed and built WHP. The new GMP cleanroom is part of ADC Bio’s […]

ARECOR SIGNS A NEW FORMULATION EVALUATION AGREEMENT WITH AN EXISTING PARTNER, A MAJOR GLOBAL PHARMACEUTICAL COMPANY

Link to Full Article Cambridge, UK., 9th July 2019: Arecor Ltd (“Arecor” or “the Company”), the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, today announces that it has signed a further collaboration with a major global pharmaceutical company. Under this […]

RECELL® System Feasibility Study Results for Treatment of Diabetic Foot Ulcers Presented at 11th Annual Congress of the Japanese Society of Limb Salvage & Podiatric Medicine

Link to Full Article Innovative regenerative technology using patients’ own skin cells significantly reduced size of wounds caused diabetic foot ulcers in all patients Valencia, Calif., USA, and Melbourne, Australia, 01 July 2019 — AVITA Medical (ASX: AVH, OTCQX: AVMXY) a global regenerative medicine company, announced today favorable results from an open-label feasibility study […]

THERMORESPONSIVE 3D CELL CULTURE SCAFFOLDS

Link to Full Article A publication in Acta Biomaterialia  a team at Nottingham University, led Profs Felicity Rose and Cameron Alexander, describes how a thermoresponsive polymer can be incorporated into 3D cell culture scaffolds to facilitate cell release. This thermoresponsive electrospun scaffold system combines the advantages of providing a physiologically relevant environment to maintain a […]

The ADC Market is Fast Evolving

Link to Full Article Applications of ADCs are widening and improvements in the manufacturing process meet industry requirements. Charlie Johnson, CEO, ADC Bio06.13.19 The scale of patient demand has fueled an overarching healthcare market need to expand the drug development pipeline to generate more biologics to treat multiple diseases and innovative new biopharmaceuticals to further […]

AVITA Medical Announces RECELL® System Preliminary Data Focused on Vitiligo and Facial Acne Scars at the 24th Annual World Congress of Dermatology

Link to Full Article Abstracts Showcase Research on Potential Use of RECELL® System in Regenerative Dermatology Valencia, Calif., USA, and Melbourne, Australia, June 12, 2019 —AVITA Medical (ASX: AVH, OTCQX: AVMXY), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announces new preliminary RECELL® Autologous Cell […]